We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
As with any medicinal product, the MHRA will keep the safety and effectiveness of nerandomilast under close review.
This guidance is intended to support billing authorities in administering the 2025/26 Retail, Hospitality and Leisure Business Rates Relief Scheme.
Product Recall for Nov'Max Anti Volume Keratin Hair Treatment presenting a serious chemical risk.
The Prime Minister used his first speech in office to launch an urgent national drive to end rough sleeping at the earliest opportunity, setting out a bold ambition to tackle one of the starkest injustices in the country. This will...
How to use RamaXL, including system availability, running reports and how to subscribe.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).